Home > Abdulraheem Yacoub, ASH 2019: Novel Agents for the Treatment of PV and MF
Haematology

Abdulraheem Yacoub, ASH 2019: Novel Agents for the Treatment of PV and MF

Published Online: December 18th 2019

At the 61st ASH Annual Meeting & Exposition, Abdulraheem Yacoub, University of Kansas Medical Center, discusses his presentation: MPN Tumor Board: Application of Novel Agents for the Treatment of Polycythemia Vera and Myelofibrosis.

Questions

1. What are the most exciting recent advances in the treatment of polycythemia vera and myelofibrosis? (0:05)

2. What role is next generation sequence technology likely to play in the future management of myeloproliferative neoplasms? (0:51)

3. How has increased understanding of these diseases helped select the most appropriate treatment strategy for an individual? (2:13)

4. What is the best treatment strategy for patients who experience symptomatic disease progression? (3:46)

5. What progress has been made in terms of combined therapy for the treatment of polycythemia vera and myelofibrosis? (6:30)

 

Abdulraheem Yacoub has been a consultant for Incyte, Novartis and Agios.

Filmed at the 61st ASH Annual Meeting & Exposition 2019, Orlando, FL, USA.

Related Videos In Haematology
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar